We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$158M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$70.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$34.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.9M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IHRT icon
3451
iHeartMedia
IHRT
$446M
$31.5K ﹤0.01%
28,922
+27,591
+2,073% +$43K
METC icon
3452
Ramaco Resources Class A
METC
$685M
$31.5K ﹤0.01%
2,617
-17,061
-87% -$237K
GBTG icon
3453
American Express Global Business Travel
GBTG
$4.94B
$31.5K ﹤0.01%
4,770
+3,435
+257% +$21.1K
PSEC icon
3454
Prospect Capital
PSEC
$1.15B
$31.5K ﹤0.01%
5,691
-7,732
-58% -$42.5K
INTT icon
3455
inTEST
INTT
$178M
$31.4K ﹤0.01%
3,182
+2,067
+185% +$22.1K
GIL icon
3456
Gildan
GIL
$10.6B
$31.4K ﹤0.01%
829
-15,201
-95% -$550K
AVIR icon
3457
Atea Pharmaceuticals
AVIR
$411M
$31.4K ﹤0.01%
9,482
+8,012
+545% +$29.9K
TLS icon
3458
Telos
TLS
$327M
$31.4K ﹤0.01%
7,805
-3,048
-28% -$11.6K
QUAD icon
3459
Quad
QUAD
$509M
$31.3K ﹤0.01%
5,750
+3,470
+152% +$17K
TCBX icon
3460
Third Coast Bancshares
TCBX
$758M
$31.3K ﹤0.01%
1,472
+308
+26% +$6.17K
LCTX icon
3461
Lineage Cell Therapeutics
LCTX
$281M
$31.1K ﹤0.01%
31,177
+30,205
+3,108% +$33.4K
BTE icon
3462
Baytex Energy
BTE
$3.05B
$31.1K ﹤0.01%
8,923
-48,901
-85% -$175K
FEAM icon
3463
5E Advanced Materials
FEAM
$71.4M
$31K ﹤0.01%
1,115
+706
+173% +$22.1K
CRBP icon
3464
Corbus Pharmaceuticals
CRBP
$188M
$31K ﹤0.01%
686
-1,040
-60% -$43.7K
GOOS
3465
Canada Goose Holdings
GOOS
$847M
$31K ﹤0.01%
2,400
-1,879
-44% -$23.3K
SCPH
3466
DELISTED
scPharmaceuticals
SCPH
$31K ﹤0.01%
7,130
-3,525
-33% -$15.5K
PSNL icon
3467
Personalis
PSNL
$1.52B
$31K ﹤0.01%
26,505
+1,479
+6% +$2.03K
CIX icon
3468
Comp X International
CIX
$391M
$31K ﹤0.01%
1,256
+191
+18% +$5.3K
SPWH icon
3469
Sportsman's Warehouse
SPWH
$46M
$31K ﹤0.01%
12,854
+11,890
+1,233% +$37.8K
GGB icon
3470
Gerdau
GGB
$9.48B
$30.9K ﹤0.01%
9,361
-13,221
-59% -$46.7K
DH icon
3471
Definitive Healthcare
DH
$69M
$30.8K ﹤0.01%
5,650
+4,459
+374% +$28.1K
GCO icon
3472
Genesco
GCO
$391M
$30.8K ﹤0.01%
1,192
-40
-3% -$1.05K
FEZ icon
3473
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.55B
$30.8K ﹤0.01%
616
+489
+385% +$25.4K
NOMD icon
3474
Nomad Foods
NOMD
$1.6B
$30.8K ﹤0.01%
1,870
-1,221
-40% -$22K
GSL icon
3475
Global Ship Lease
GSL
$1.48B
$30.7K ﹤0.01%
1,067
-136
-11% -$3.45K
137 138
139
140 141

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.